TENAX THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tenax Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Tenax Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $3.67M, a 197% increase year-over-year.
  • Tenax Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $8.3M, a 60.6% increase year-over-year.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $8.23M, a 25.5% decline from 2022.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $11.1M.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$32.7M, a 432% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.3M $3.67M +$2.44M +197% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $5.87M -$3.91M -$2.37M -154% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $8.23M $6.42M +$3.87M +151% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $4.37M $2.12M -$800K -27.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.17M $1.24M -$1.63M -56.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $6.79M -$1.54M -$4.26M -157% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $11.1M $2.55M +$64.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$53.7M $2.92M -$885K -23.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$52.9M $2.86M +$897K +45.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$53.8M $2.72M -$21M -88.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$32.7M -$62.2M -$65.1M -2297% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $32.3M $3.8M +$1.58M +70.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $30.8M $1.96M -$180K -8.37% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $31M $23.7M +$21.1M +791% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $9.87M $2.83M +$17.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$7.26M $2.23M -$35.3K -1.56% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$7.23M $2.14M +$324K +17.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$7.55M $2.67M +$1M +60.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$8.56M -$14.3M -$2.74M -23.7% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 -$5.82M $2.26M +$706K +45.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$6.52M $1.82M -$69.2K -3.66% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$6.45M $1.66M +$439K +35.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$6.89M -$11.6M +$5.47M +32.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$12.4M $1.55M +$244K +18.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$12.6M $1.89M -$1.13M -37.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$11.5M $1.22M -$2.28M -65% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$9.21M -$17M +$39.1M +69.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$48.3M $1.31M -$3.19M -70.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$45.1M $3.01M -$1.66M -35.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$43.4M $3.5M +$9.2M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$52.7M -$56.1M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $4.5M +$7.6M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $4.67M +$9.54M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$5.71M -$2.5M -78.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 -$14.3M -$3.1M +$1.04M +25.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$15.3M -$4.87M -$2.45M -101% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$12.9M -$3.2M +$7.27M +69.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$20.2M -$3.13M -$703K -28.9% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-17
Q3 2014 -$19.5M -$4.14M -$2.03M -96% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 -$17.4M -$2.42M -$827K -52% May 1, 2014 Jul 31, 2014 10-Q 2015-09-09
Q1 2014 -$16.6M -$10.5M -$9.24M -745% Feb 1, 2014 Apr 30, 2014 10-K 2017-03-16
Q4 2013 -$7.37M -$2.43M -$840K -52.8% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$6.53M -$2.11M -$1.43M -210% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 -$5.1M -$1.59M +$85.8K +5.12% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$5.19M -$1.24M +$625K +33.5% Feb 1, 2013 Apr 30, 2013 10-KT 2016-03-14
Q4 2012 -$5.81M -$1.59M +$282K +15.1% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$6.1M -$683K +$1.37M +66.8% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-17
Q2 2012 -$7.47M -$1.68M +$753K +31% May 1, 2012 Jul 31, 2012 10-Q 2013-09-17
Q1 2012 -$8.22M -$1.86M -$4.59M -168% Feb 1, 2012 Apr 30, 2012 10-K 2013-06-26
Q4 2011 -$3.63M -$1.87M -$4.63M -168% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $1M -$2.05M -$4.11M -200% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 $5.11M -$2.43M -$5.45M -180% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q1 2011 $10.6M $2.73M Feb 1, 2011 Apr 30, 2011 10-K 2012-07-25
Q4 2010 $2.75M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-15
Q3 2010 $2.06M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 $3.02M May 1, 2010 Jul 31, 2010 10-Q 2011-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.